Skip to content
MedsAcross

Medicine

Flucytosine 250 mg capsule

Flucytosine · Oral
Available on requestPrescription onlyUS FDAGeneric name

Flucytosine 250 mg capsule is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).

Key facts

Active ingredient (INN)
Flucytosine
Brand
Sold under the generic name
Strength
250 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules, 30 capsules, 10 blister pack and 8 more
Manufacturers
Avet PharmaceuticalsIndiaLaurus LabsIndiaNovel LaboratoriesIndiaAurobindo PharmaIndiaAmerican Health PackagingAvPAKMajor PharmaceuticalsSigmapharm Laboratories9 labelers on the register
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D01AE21 Flucytosine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
7 July 2017
Identifiers
RxCUI 197702, 197703DailyMed set ID f4c63d98-f03f-43f5-8c1f-e9ac6087312b, ee98e0a9-c125-4b5c-ba4e-ca3c9a1f2b90, 4b1c40b2-e0fb-47d5-b821-889b3090cebe +6NDC 23155-860, 40032-771, 60687-599 +6Application ANDA212632, ANDA204652, ANDA213665 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 capsule in 1 bottle59651-331-01Aurobindo PharmaIndia1 May 2020
100 capsule in 1 bottle23155-860-01Avet PharmaceuticalsIndia25 June 2023
30 capsule in 1 bottle23155-860-03Avet PharmaceuticalsIndia25 June 2023
100 capsule in 1 bottle42385-983-01Laurus LabsIndia24 July 2025
10 blister pack in 1 carton / 10 capsule in 1 blister pack42385-983-27Laurus LabsIndia24 July 2025
100 capsule in 1 bottle40032-771-01Novel LaboratoriesIndia7 July 2017
30 capsule in 1 bottle40032-771-03Novel LaboratoriesIndia7 July 2017
30 capsule in 1 bottle42794-009-08Sigmapharm Laboratories1 June 2018
30 blister pack in 1 box, unit-dose / 1 capsule in 1 blister pack60687-599-21American Health Packaging17 December 2021
20 blister pack in 1 box / 1 capsule in 1 blister pack50268-331-12AvPAK12 April 2021
30 blister pack in 1 carton / 1 capsule in 1 blister pack0904-6834-07Major Pharmaceuticals7 July 2017

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 26 November 1971Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Flucytosine 250 mg capsule.

Compare 1

Other strengths and forms of Flucytosine

Clinical summary

Flucytosine is a nucleoside analog antifungal indicated only in the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus. It is available as capsules for oral use. MedsAcross supplies Flucytosine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Flucytosine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Flucytosine 250 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.